Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Concomitant Guillain Barre Syndrome and Transverse Myelitis as Initial Neuropsychiatric Manifestation in a Case of Lupus: A Diagnostic Quandary.
Respiratory Muscle Assessment in Acute Guillain-Barré Syndrome.
A survey study comparing young adults with MS and healthy controls on self-esteem, self-efficacy, mood and quality of life.
The devil is in the detail: Acute Guillain-Barré syndrome camouflaged as neurosarcoidosis in a critically ill patient admitted to an Intensive Care Unit.
Development and Feasibility of an Evidence-Based Patient Education Program for Managing Fatigue in Multiple Sclerosis: The "Fatigue Management in MS" Program (FatiMa).
The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
Neurofilament light chain level is a weak risk factor for the development of MS.
Autonomic function and brain volume.
Pre-operative declining proportion of fractional anisotropy of trigeminal nerve is correlated with the outcome of micro-vascular decompression surgery.
Posterior reversible encephalopathy syndrome (PRES) as a complication of Guillain-Barre' syndrome (GBS).
Insights into the Pathogenesis and Treatment of Krabbe Disease.
Capparis ovata treatment suppresses inflammatory cytokine expression and ameliorates experimental allergic encephalomyelitis model of multiple sclerosis in C57BL/6 mice.
The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.
Development and Validity of Western University's On-Road Assessment.
Environmental and genetic factors in pediatric inflammatory demyelinating diseases.
MicroRNA 182 inhibits CD4(+)CD25(+)Foxp3(+) Treg differentiation in experimental autoimmune encephalomyelitis.
Corrigendum.
Pre-surgical CT-assessment of neurogenic myositis ossificans of the hip and risk factors of recurrence: a series of 101 consecutive patients.
Epidemiology of multiple sclerosis.
Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis.
Study Confirms Natalizumab Efficacy, Safety in Treating RRMS
Protective Effects on Central Nervous System by Acidic Polysaccharide of Panax ginseng in Relapse-Remitting Experimental Autoimmune Encephalomyelitis-Induced SJL/J Mice.
Mevalonate Cascade and small Rho GTPase in Spinal Cord Injury.
Assessment of IL-17A, IL-10 and TGF-beta1 serum titers in RRMS patients treated with Avonex, possible biomarkers for treatment response.
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.

Pages